SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-299395
Filing Date
2020-11-20
Accepted
2020-11-20 16:08:56
Documents
16
Period of Report
2020-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d27452d8k.htm   iXBRL 8-K 34013
2 EX-1.1 d27452dex11.htm EX-1.1 162385
3 EX-5.1 d27452dex51.htm EX-5.1 6412
4 EX-99.1 d27452dex991.htm EX-99.1 8871
5 EX-99.2 d27452dex992.htm EX-99.2 8996
  Complete submission text file 0001193125-20-299395.txt   408299

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20201119.xsd EX-101.SCH 3067
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20201119_lab.xml EX-101.LAB 19657
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20201119_pre.xml EX-101.PRE 12313
9 EXTRACTED XBRL INSTANCE DOCUMENT d27452d8k_htm.xml XML 3593
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 201332550
SIC: 2836 Biological Products, (No Diagnostic Substances)